You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Keep People Moving
At DePuy Synthes, we have a powerful vision — to Keep People Moving. Movement is essential to how we experience life. When we move better, we feel better, we connect better – we live better. We have been committed to changing the trajectory of orthopaedic care for more than 125 years.
At DePuy Synthes, we are reimagining orthopaedics so we can Keep People Moving today and tomorrow.
Powering Insight-Driven Care Before, During and After Surgery
At DePuy Synthes, we are blending our long-standing leadership in orthopaedic innovation with an accelerating focus on enabling and digital technologies to advance patient care.
With VELYS™ Digital Surgery, we are building a platform of connected technologies powered by data insights before, during, and after surgery and designed to elevate the orthopaedic experience for patients, surgeons and care teams.
Total Knee Arthroplasty
Three Advanced Components, One Revolutionary Surgical Solution
DePuy Synthes is enabling surgeons to restore patient knee function sooner1-3 with next level patient satisfaction4, by offering an end-to-end solution. This single solution combines the ATTUNE® Knee System with the proprietary Patient-Specific Techniques, and VELYS™ Robotic-Assisted Solution to help enhance surgical accuracy, precision and predictability. Surgeons enjoy greater ease of use. Patients get back on their feet, faster1-3. One knee solution, endless steps forward.
VELYS™ Hip Navigation and the Posterior Approach
Since the launch of VELYS™ Hip Navigation in 2018, more than 46,0005 non-invasive, software-navigated total hip arthroplasties have been performed globally, primarily using the anterior approach. To address the needs of surgeons using a posterior approach, DePuy Synthes has introduced a new 3.0 software update that includes new image guidance for ONETRIAL™ Analysis, a feature that enables intraoperative data-driven decision making. Functionality of the 3.0 software utilizes the same x-rays for both supine and lateral positioned hip approaches and the image guidance provides surgeons with feedback on x-ray consistency and c-arm positioning which improves the output of data. VELYS Hip Navigation provides actionable, real-time data designed to help with increased accuracy and surgical reproducibility, reduced OR time, and improved patient outcomes.
Explore our Scientific Evidence
Exclusively preview valuable clinical research and scientific data presented during the first virtual Global Orthopaedic & MedTech Summit presented by DePuy Synthes. More than 100 scientific poster presentations and abstracts are available on demand representing the scientific research associated with our major orthopaedic specialties.
DYNACORD™ Suture: A Summary of the in vivo Preclinical Evidence
David Spenciner, Mackenzie Mallard, Dennis Connelly, Vivian Liang
Effect of surgical positioning on the risk of edge loading in Total Hip Replacement: in-vitro and in-silico simulation
Lin Wang, Mazen Al Hajjar, John Fisher, Jonathan Thompson
Benchtop Positional Accuracy Assessment of a Robotic-Assisted Surgical System Using Digital Image Correlation
Kelly L Mote, Thomas W McDowell IV, Joseph Wyss
Enhanced Hip Tribological and Mechanical Properties of AOX™ UHMWPE Blend
Elizabeth Hippensteel and Bharat Patel, PhD
CORAIL® Collared Hip System collared provides increased protection against risk of femoral fracture, registry analysis backed up by biomechanical study
Isaiah Adekanmbi, David Horne, Jonathan N Lamb, Johanna Baetz, Philipp Messer-Hannemann, Michael M Morlock, Hemant G Pandit
About DePuy Synthes
DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive Orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow.
DePuy Synthes Illustrates the Future of a Connected OR with its Expanding VELYS™ Digital Surgery Platform at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
DePuy Synthes Introduces the INHANCE™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
DePuy Synthes Launches 2.7 mm Variable Angle Locking Compression Plate Clavicle System Designed to Accommodate Different Shapes and Sizes of the Collarbone
1. van Loon C, Meermans G, Baas N, et al. Early recovery Rate After A new Design Total Knee Arthroplasty (TKA): A Prospective, Multicenter Cohort of 200 Cases. 2nd World Arthroplasty Congress. Rome, April 19-21, 2018.
2. Clatworthy, M. (2015). An Early Outcome Study of the ATTUNE® Knee System vs. the SIGMA® CR150 Knee System. DePuy Synthes Companies White Paper. 100959-181017 DSUS/EM. In hospital study involved 40 ATTUNE Knee vs 40 SIGMA Knee patients.
3. Etter K, Lerner J, de Moor C, Yoo A, Kalsekar I. Comparative Analysis of Hospital Length of Stay and Discharge Status of Two Contemporary Primary Total Knee Systems. Journal of Knee Surgery. 2017; 193: 1-33. DOI https://doi.org/10.1055/s-0037-1604442. Premier Perspective™ Database analysis including 38 hospitals, representing 1,178 primary, unilateral TKAs with the ATTUNE Knee and 5,707 primary, unilateral TKAs with Triathlon™.
4. National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. Implant Summary Report for DePuy ATTUNE CR and ATTUNE PS. NJR Database extract May 6, 2021, page 14. Licensed for use until May 18, 2022, Available at www.ATTUNEevidence.com (US) and www.provingthepromise.com (EMEA)
5. DePuy Synthes Worldwide VHN Case Report. 2018 – 2021
This site is published by the DePuy Synthes Companies, which are solely responsible for its content.
This site is for visitors from the United States.
The third-party trademarks used herein are trademarks of their respective owners.
Please refer to the instructions for use for a complete list of indications, contraindications, warnings and precautions.